Cost-effectiveness analysis of pegylated liposomal doxorubicin combined with chemotherapy in the treatment of recurrent ovarian cancer

ZHANG Qi-lin, DING Yu-feng, QIN Yan-jie, DAI Bing, SHU Ya-min

Chinese Journal of Hospital Pharmacy ›› 2021, Vol. 41 ›› Issue (22) : 2322-2327.

PDF(2538 KB)
PDF(2538 KB)
Chinese Journal of Hospital Pharmacy ›› 2021, Vol. 41 ›› Issue (22) : 2322-2327. DOI: 10.13286/j.1001-5213.2021.22.09
CONTENTS IN BRIEF

Cost-effectiveness analysis of pegylated liposomal doxorubicin combined with chemotherapy in the treatment of recurrent ovarian cancer

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2021, 41(22): 2322-2327 https://doi.org/10.13286/j.1001-5213.2021.22.09

References

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(2538 KB)

Accesses

Citation

Detail

Sections
Recommended

/